Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

127 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Pregnancy After Breast Cancer in Patients With Germline BRCA Mutations.
Lambertini M, Ameye L, Hamy AS, Zingarello A, Poorvu PD, Carrasco E, Grinshpun A, Han S, Rousset-Jablonski C, Ferrari A, Paluch-Shimon S, Cortesi L, Senechal C, Miolo G, Pogoda K, Pérez-Fidalgo JA, De Marchis L, Ponzone R, Livraghi L, Estevez-Diz MDP, Villarreal-Garza C, Dieci MV, Clatot F, Berlière M, Graffeo R, Teixeira L, Córdoba O, Sonnenblick A, Luna Pais H, Ignatiadis M, Paesmans M, Partridge AH, Caron O, Saule C, Del Mastro L, Peccatori FA, Azim HA Jr. Lambertini M, et al. Among authors: azim ha jr. J Clin Oncol. 2020 Jul 16:JCO1902399. doi: 10.1200/JCO.19.02399. Online ahead of print. J Clin Oncol. 2020. PMID: 32673153
Estimation of historical control rate for a single arm de-escalation study - Application to the POSITIVE trial.
Sun Z, Niman SM, Pagani O, Partridge AH, Azim HA Jr, Peccatori FA, Ruggeri M, Di Leo A, Colleoni M, Gelber RD, Regan MM; POSITIVE Steering Committee. Sun Z, et al. Among authors: azim ha jr. Breast. 2020 Jun 2;53:1-7. doi: 10.1016/j.breast.2020.05.012. Online ahead of print. Breast. 2020. PMID: 32535486 Free PMC article.
Adjuvant ovarian function suppression and tamoxifen in premenopausal breast cancer patients: A meta-analysis.
Azim HA, Shohdy KS, Kaldas DF, Kassem L, Azim HA Jr. Azim HA, et al. Among authors: azim ha jr. Curr Probl Cancer. 2020 May 26:100592. doi: 10.1016/j.currproblcancer.2020.100592. Online ahead of print. Curr Probl Cancer. 2020. PMID: 32527567
Fertility preservation in patients with BRCA mutation.
Ghunaim S, Ghazeeri G, Khalife D, Azim HA Jr. Ghunaim S, et al. Among authors: azim ha jr. Ecancermedicalscience. 2020 May 6;14:1033. doi: 10.3332/ecancer.2020.1033. eCollection 2020. Ecancermedicalscience. 2020. PMID: 32419845 Free PMC article. Review.
ESO-ESMO 4th International Consensus Guidelines for Breast Cancer in Young Women (BCY4).
Paluch-Shimon S, Cardoso F, Partridge AH, Abulkhair O, Azim HA Jr, Bianchi-Micheli G, Cardoso MJ, Curigliano G, Gelmon KA, Harbeck N, Merschdorf J, Poortmans P, Pruneri G, Senkus E, Spanic T, Stearns V, Wengström Y, Peccatori F, Pagani O. Paluch-Shimon S, et al. Among authors: azim ha jr. Ann Oncol. 2020 Mar 19:S0923-7534(20)36363-8. doi: 10.1016/j.annonc.2020.03.284. Online ahead of print. Ann Oncol. 2020. PMID: 32199930
Understanding the benefits and challenges of first-line cyclin-dependent kinases 4 and 6 inhibitors in advanced breast cancer among postmenopausal women.
Azim HA, Dawood S, El-Saghir N, Kassem L, Azim HA Jr. Azim HA, et al. Among authors: azim ha jr. Breast J. 2020 Apr;26(4):630-642. doi: 10.1111/tbj.13637. Epub 2019 Nov 10. Breast J. 2020. PMID: 31709685
Lucitanib for the Treatment of HR+/HER2- Metastatic Breast Cancer: Results from the Multicohort Phase II FINESSE Study.
Hui R, Pearson A, Cortes J, Campbell C, Poirot C, Azim HA Jr, Fumagalli D, Lambertini M, Daly F, Arahmani A, Perez-Garcia J, Aftimos P, Bedard PL, Xuereb L, Scheepers ED, Vicente M, Goulioti T, Loibl S, Loi S, Pierrat MJ, Turner NC, Andre F, Curigliano G. Hui R, et al. Among authors: azim ha jr. Clin Cancer Res. 2020 Jan 15;26(2):354-363. doi: 10.1158/1078-0432.CCR-19-1164. Epub 2019 Oct 16. Clin Cancer Res. 2020. PMID: 31619444
Dose-Ranging and Cohort-Expansion Study of Monalizumab (IPH2201) in Patients with Advanced Gynecologic Malignancies: A Trial of the Canadian Cancer Trials Group (CCTG): IND221.
Tinker AV, Hirte HW, Provencher D, Butler M, Ritter H, Tu D, Azim HA Jr, Paralejas P, Grenier N, Hahn SA, Ramsahai J, Seymour L. Tinker AV, et al. Among authors: azim ha jr. Clin Cancer Res. 2019 Oct 15;25(20):6052-6060. doi: 10.1158/1078-0432.CCR-19-0298. Epub 2019 Jul 15. Clin Cancer Res. 2019. PMID: 31308062
IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial.
Bagot M, Porcu P, Marie-Cardine A, Battistella M, William BM, Vermeer M, Whittaker S, Rotolo F, Ram-Wolff C, Khodadoust MS, Bensussan A, Paturel C, Bonnafous C, Sicard H, Azim HA Jr, Kim YH. Bagot M, et al. Among authors: azim ha jr. Lancet Oncol. 2019 Aug;20(8):1160-1170. doi: 10.1016/S1470-2045(19)30320-1. Epub 2019 Jun 25. Lancet Oncol. 2019. PMID: 31253572 Clinical Trial.
Knowledge, attitudes and practice of physicians towards fertility and pregnancy-related issues in youngBRCA-mutated breast cancer patients.
Lambertini M, Di Maio M, Poggio F, Pagani O, Curigliano G, Mastro LD, Paluch-Shimon S, Loibl S, Partridge AH, Azim HA Jr, Peccatori FA, Demeestere I. Lambertini M, et al. Among authors: azim ha jr. Reprod Biomed Online. 2019 May;38(5):835-844. doi: 10.1016/j.rbmo.2018.11.031. Epub 2019 Jan 10. Reprod Biomed Online. 2019. PMID: 30914152
127 results
Jump to page
Feedback